Current and Resolved Drug Shortages and Discontinuations Reported to FDA
Report a Drug Shortage |
FAQ |
Background Info |
Get Email Alerts |
Download Current Drug Shortages |
Contact Us
Start Over | Back to Previous Screen
Methylprednisolone Acetate Injection
Status: Currently in Shortage
»Date first posted:
12/15/2021
»Therapeutic Categories: Rheumatology
Amneal Pharmaceuticals (Revised 07/09/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Injection, 40 mg/1 mL (NDC 70121-1573-1) | Available | Sufficient Inventory available (02 to 04 Wk) as per current demand. Next Supply from wk. of 14th July-24 | |
| Injection, 40 mg/1 mL (NDC 70121-1573-5) | Available | Sufficient Inventory available (02 to 04 Wk) as per current demand. Next Supply from wk. of 7th July-24 | |
| Injection, 80 mg/1 mL (NDC 70121-1574-1) | Available | Sufficient Inventory available (02 to 04 Wk) as per current demand. Next Supply from wk. of 7th July-24 | |
| Injection, 80 mg/1 mL (NDC 70121-1574-5) | Available | Available Inventory for 1 week as per current demand. Next Supply from wk. of 14th July-24 |
Eugia US LLC (Reverified 08/05/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Injection, 40 mg/1 mL (NDC 55150-313-01) | Available | Check wholesalers for inventory | |
| Injection, 80 mg/1 mL (NDC 55150-314-01) | Unavailable | On backorder. Recovery: TBD. Check wholesalers for inventory | Demand increase for the drug |
Par Pharmaceutical, Inc. (Revised 09/03/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Injection, 80 mg/1 mL (NDC 42023-240-01) | Unavailable | Recovery: Nov 2024 | Other |
Pfizer Inc. (Reverified 08/26/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Depo-medrol, Injection, 20 mg/1 mL (NDC 0009-0274-01) | Available | ||
| Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-02) | Available | ||
| Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-03) | Available | ||
| Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-51) | Available | ||
| Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-52) | Available | ||
| Depo-medrol, Injection, 80 mg/1 mL (NDC 0009-0306-02) | Available | ||
| Depo-medrol, Injection, 80 mg/1 mL (NDC 0009-0306-12) | Available | ||
| Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-3073-01) | Limited Supply Available. Next Delivery: August 2024; Estimated Recovery: September 2024 | check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay | Delay in shipping of the drug |
| Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-3073-03) | Available | ||
| Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-3073-22) | Available | ||
| Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-3073-23) | Available | ||
| Depo-medrol, Injection, 80 mg/1 mL (NDC 0009-3475-01) | Available | ||
| Depo-medrol, Injection, 80 mg/1 mL (NDC 0009-3475-03) | Next Delivery: August 2024; Estimated Recovery: September 2024 | shortage per Manufacturer: Manufacturing Delay | Delay in shipping of the drug |
Sagent Pharmaceuticals (Reverified 07/01/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Injection, 40 mg/1 mL (NDC 25021-820-10) | Available | ||
| Injection, 40 mg/1 mL (NDC 25021-820-05) | Available | ||
| Injection, 80 mg/1 mL (NDC 25021-821-05) | Available |